
    
      Children aged 3-7 years diagnosed with autistic spectrum disorder and who did not previously
      receive oxytocin or umbilical cord blood treatments, will be enrolled to receive both
      treatments in random order. Assessment of functioning impairment will be done with
      QCHAT/M-CHAT/CAST questionnaires initially, at 2 months, 6 months and 1 year after first
      treatments. Either oxytocin or cord blood will be administered initially and at visit 2,
      which will take place at 2 months. All children will receive both treatments. A total of
      25-40 children are expected to enroll and complete the study.
    
  